Trial intelligence / Profile preview

Prediction of Morphine Response in Neuropathic Pain

NCT01914042Phase 2Unknown

Sponsor
Rambam Health Care Campus
Start
Jul 2013
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of morphine in neuropathic pain, sponsored by Rambam Health Care Campus. Status: unknown.

02

Drugs

morphine
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT01914042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01914042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call